Literature DB >> 17549285

Chemotherapy in adults with gliomas.

Siew-Ju See1, Mark R Gilbert.   

Abstract

Treating patients with gliomas requires a multidisciplinary approach, which often includes surgery, radiation and chemotherapy. Recent developments have demonstrated the efficacy of chemotherapeutic agents in patients with newly diagnosed or recurrent gliomas. Large clinical studies have provided important information on the impact of chemotherapy for anaplastic oligodendrogliomas in the upfront setting. Randomised trials have demonstrated the benefit of chemoradiation for patients with glioblastoma. Investigations are also under way to clarify the role of chemotherapy for low-grade gliomas. This review article summarises the recent developments and approaches in the use of chemotherapy to treat adult patients with astrocytomas and oligodendrogliomas.

Entities:  

Mesh:

Year:  2007        PMID: 17549285

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

1.  Chemotherapeutic resistance in anaplastic astrocytoma cell lines treated with a temozolomide-lomeguatrib combination.

Authors:  Hasan Caglar Ugur; Mehmet Taspinar; Seda Ilgaz; Fatma Sert; Hande Canpinar; Juan A Rey; Javier S Castresana; Asuman Sunguroglu
Journal:  Mol Biol Rep       Date:  2013-12-25       Impact factor: 2.316

2.  Low-grade gliomas in adults.

Authors:  Sandeep Mittal; Mark C Szlaczky; Geoffrey R Barger
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.